Home > > > > > Report Detail

Global Multiple Sclerosis Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Publisher Name :
Date: 11-Jan-2019
No. of pages: 128

Multiple sclerosis is a chronic, inflammatory medical condition, which results in demyelination, axonal transection, and neurodegeneration of the nerve cells of the brain and spinal cord. The immune system of the body targets the neurons within the CNS and damages the myelin sheath. It is a potentially debilitating disease, causing disruption in the communication and coordination functions of the body. The symptoms of multiple sclerosis differ widely, subject to the extent of damage and the number of neurons affected. Some of the symptoms observed are fatigue, numbness, spasticity, bladder dysfunction, cognitive changes, emotional changes, and depression. An individual with severe form of the disease can experience speech and movement problems.

Scope of the Report:

This report studies the Multiple Sclerosis market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Multiple Sclerosis market by product type and applications/end industries.

Nevertheless, the leading pharmaceutical companies operating in North America and Europe is shifting the focus on Asia-pacific region due to the growing demand for effective and economic MS treatment. . Pharmaceutical companies belong to developed regions are focusing on the commercialization of novel therapeutics having minimal side effects and economic pricing. Such product launch strategy would provide an opportunity for the pharmaceutical companies across developing economies. Furthermore, the market is majorly supplemented by increasing funding from government authorities for research and development.

The global Multiple Sclerosis market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Multiple Sclerosis.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

- Abbvie

- Acorda Therapeutics

- Bayer HealthCare

- Biogen

- Genzyme (Sanofi)

- GlaxoSmithKline

- Merck Serono

- Novartis

- Pfizer

- Teva

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Injectable agents

- Oral agents

Market Segment by Applications, can be divided into

- Hosptial

- Research

Global Multiple Sclerosis Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Table of Contents

1 Multiple Sclerosis Market Overview
1.1 Product Overview and Scope of Multiple Sclerosis
1.2 Classification of Multiple Sclerosis by Types
1.2.1 Global Multiple Sclerosis Revenue Comparison by Types (2017-2023)
1.2.2 Global Multiple Sclerosis Revenue Market Share by Types in 2017
1.2.3 Injectable agents
1.2.4 Oral agents
1.3 Global Multiple Sclerosis Market by Application
1.3.1 Global Multiple Sclerosis Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hosptial
1.3.3 Research
1.4 Global Multiple Sclerosis Market by Regions
1.4.1 Global Multiple Sclerosis Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Multiple Sclerosis Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Multiple Sclerosis Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Multiple Sclerosis Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Multiple Sclerosis Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Multiple Sclerosis Status and Prospect (2013-2023)
1.5 Global Market Size of Multiple Sclerosis (2013-2023)
2 Manufacturers Profiles
2.1 Abbvie
2.1.1 Business Overview
2.1.2 Multiple Sclerosis Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbvie Multiple Sclerosis Revenue, Gross Margin and Market Share (2016-2017)
2.2 Acorda Therapeutics
2.2.1 Business Overview
2.2.2 Multiple Sclerosis Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Acorda Therapeutics Multiple Sclerosis Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bayer HealthCare
2.3.1 Business Overview
2.3.2 Multiple Sclerosis Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bayer HealthCare Multiple Sclerosis Revenue, Gross Margin and Market Share (2016-2017)
2.4 Biogen
2.4.1 Business Overview
2.4.2 Multiple Sclerosis Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Biogen Multiple Sclerosis Revenue, Gross Margin and Market Share (2016-2017)
2.5 Genzyme (Sanofi)
2.5.1 Business Overview
2.5.2 Multiple Sclerosis Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Genzyme (Sanofi) Multiple Sclerosis Revenue, Gross Margin and Market Share (2016-2017)
2.6 GlaxoSmithKline
2.6.1 Business Overview
2.6.2 Multiple Sclerosis Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 GlaxoSmithKline Multiple Sclerosis Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck Serono
2.7.1 Business Overview
2.7.2 Multiple Sclerosis Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck Serono Multiple Sclerosis Revenue, Gross Margin and Market Share (2016-2017)
2.8 Novartis
2.8.1 Business Overview
2.8.2 Multiple Sclerosis Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Novartis Multiple Sclerosis Revenue, Gross Margin and Market Share (2016-2017)
2.9 Pfizer
2.9.1 Business Overview
2.9.2 Multiple Sclerosis Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pfizer Multiple Sclerosis Revenue, Gross Margin and Market Share (2016-2017)
2.10 Teva
2.10.1 Business Overview
2.10.2 Multiple Sclerosis Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Teva Multiple Sclerosis Revenue, Gross Margin and Market Share (2016-2017)
3 Global Multiple Sclerosis Market Competition, by Players
3.1 Global Multiple Sclerosis Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Multiple Sclerosis Players Market Share
3.2.2 Top 10 Multiple Sclerosis Players Market Share
3.3 Market Competition Trend
4 Global Multiple Sclerosis Market Size by Regions
4.1 Global Multiple Sclerosis Revenue and Market Share by Regions
4.2 North America Multiple Sclerosis Revenue and Growth Rate (2013-2018)
4.3 Europe Multiple Sclerosis Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Multiple Sclerosis Revenue and Growth Rate (2013-2018)
4.5 South America Multiple Sclerosis Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Multiple Sclerosis Revenue and Growth Rate (2013-2018)
5 North America Multiple Sclerosis Revenue by Countries
5.1 North America Multiple Sclerosis Revenue by Countries (2013-2018)
5.2 USA Multiple Sclerosis Revenue and Growth Rate (2013-2018)
5.3 Canada Multiple Sclerosis Revenue and Growth Rate (2013-2018)
5.4 Mexico Multiple Sclerosis Revenue and Growth Rate (2013-2018)
6 Europe Multiple Sclerosis Revenue by Countries
6.1 Europe Multiple Sclerosis Revenue by Countries (2013-2018)
6.2 Germany Multiple Sclerosis Revenue and Growth Rate (2013-2018)
6.3 UK Multiple Sclerosis Revenue and Growth Rate (2013-2018)
6.4 France Multiple Sclerosis Revenue and Growth Rate (2013-2018)
6.5 Russia Multiple Sclerosis Revenue and Growth Rate (2013-2018)
6.6 Italy Multiple Sclerosis Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Multiple Sclerosis Revenue by Countries
7.1 Asia-Pacific Multiple Sclerosis Revenue by Countries (2013-2018)
7.2 China Multiple Sclerosis Revenue and Growth Rate (2013-2018)
7.3 Japan Multiple Sclerosis Revenue and Growth Rate (2013-2018)
7.4 Korea Multiple Sclerosis Revenue and Growth Rate (2013-2018)
7.5 India Multiple Sclerosis Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Multiple Sclerosis Revenue and Growth Rate (2013-2018)
8 South America Multiple Sclerosis Revenue by Countries
8.1 South America Multiple Sclerosis Revenue by Countries (2013-2018)
8.2 Brazil Multiple Sclerosis Revenue and Growth Rate (2013-2018)
8.3 Argentina Multiple Sclerosis Revenue and Growth Rate (2013-2018)
8.4 Colombia Multiple Sclerosis Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Multiple Sclerosis by Countries
9.1 Middle East and Africa Multiple Sclerosis Revenue by Countries (2013-2018)
9.2 Saudi Arabia Multiple Sclerosis Revenue and Growth Rate (2013-2018)
9.3 UAE Multiple Sclerosis Revenue and Growth Rate (2013-2018)
9.4 Egypt Multiple Sclerosis Revenue and Growth Rate (2013-2018)
9.5 Nigeria Multiple Sclerosis Revenue and Growth Rate (2013-2018)
9.6 South Africa Multiple Sclerosis Revenue and Growth Rate (2013-2018)
10 Global Multiple Sclerosis Market Segment by Type
10.1 Global Multiple Sclerosis Revenue and Market Share by Type (2013-2018)
10.2 Global Multiple Sclerosis Market Forecast by Type (2018-2023)
10.3 Injectable agents Revenue Growth Rate (2013-2023)
10.4 Oral agents Revenue Growth Rate (2013-2023)
11 Global Multiple Sclerosis Market Segment by Application
11.1 Global Multiple Sclerosis Revenue Market Share by Application (2013-2018)
11.2 Multiple Sclerosis Market Forecast by Application (2018-2023)
11.3 Hosptial Revenue Growth (2013-2018)
11.4 Research Revenue Growth (2013-2018)
12 Global Multiple Sclerosis Market Size Forecast (2018-2023)
12.1 Global Multiple Sclerosis Market Size Forecast (2018-2023)
12.2 Global Multiple Sclerosis Market Forecast by Regions (2018-2023)
12.3 North America Multiple Sclerosis Revenue Market Forecast (2018-2023)
12.4 Europe Multiple Sclerosis Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Multiple Sclerosis Revenue Market Forecast (2018-2023)
12.6 South America Multiple Sclerosis Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Multiple Sclerosis Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Multiple Sclerosis Picture
Table Product Specifications of Multiple Sclerosis
Table Global Multiple Sclerosis and Revenue (Million USD) Market Split by Product Type
Figure Global Multiple Sclerosis Revenue Market Share by Types in 2017
Figure Injectable agents Picture
Figure Oral agents Picture
Table Global Multiple Sclerosis Revenue (Million USD) by Application (2013-2023)
Figure Multiple Sclerosis Revenue Market Share by Applications in 2017
Figure Hosptial Picture
Figure Research Picture
Table Global Market Multiple Sclerosis Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Multiple Sclerosis Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Multiple Sclerosis Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Multiple Sclerosis Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Multiple Sclerosis Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Multiple Sclerosis Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Multiple Sclerosis Revenue (Million USD) and Growth Rate (2013-2023)
Table Abbvie Basic Information, Manufacturing Base and Competitors
Table Abbvie Multiple Sclerosis Type and Applications
Table Abbvie Multiple Sclerosis Revenue, Gross Margin and Market Share (2016-2017)
Table Acorda Therapeutics Basic Information, Manufacturing Base and Competitors
Table Acorda Therapeutics Multiple Sclerosis Type and Applications
Table Acorda Therapeutics Multiple Sclerosis Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer HealthCare Basic Information, Manufacturing Base and Competitors
Table Bayer HealthCare Multiple Sclerosis Type and Applications
Table Bayer HealthCare Multiple Sclerosis Revenue, Gross Margin and Market Share (2016-2017)
Table Biogen Basic Information, Manufacturing Base and Competitors
Table Biogen Multiple Sclerosis Type and Applications
Table Biogen Multiple Sclerosis Revenue, Gross Margin and Market Share (2016-2017)
Table Genzyme (Sanofi) Basic Information, Manufacturing Base and Competitors
Table Genzyme (Sanofi) Multiple Sclerosis Type and Applications
Table Genzyme (Sanofi) Multiple Sclerosis Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Multiple Sclerosis Type and Applications
Table GlaxoSmithKline Multiple Sclerosis Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Serono Basic Information, Manufacturing Base and Competitors
Table Merck Serono Multiple Sclerosis Type and Applications
Table Merck Serono Multiple Sclerosis Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Multiple Sclerosis Type and Applications
Table Novartis Multiple Sclerosis Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Multiple Sclerosis Type and Applications
Table Pfizer Multiple Sclerosis Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Multiple Sclerosis Type and Applications
Table Teva Multiple Sclerosis Revenue, Gross Margin and Market Share (2016-2017)
Table Global Multiple Sclerosis Revenue (Million USD) by Players (2013-2018)
Table Global Multiple Sclerosis Revenue Share by Players (2013-2018)
Figure Global Multiple Sclerosis Revenue Share by Players in 2016
Figure Global Multiple Sclerosis Revenue Share by Players in 2017
Figure Global Top 5 Players Multiple Sclerosis Revenue Market Share in 2017
Figure Global Top 10 Players Multiple Sclerosis Revenue Market Share in 2017
Figure Global Multiple Sclerosis Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Multiple Sclerosis Revenue (Million USD) by Regions (2013-2018)
Table Global Multiple Sclerosis Revenue Market Share by Regions (2013-2018)
Figure Global Multiple Sclerosis Revenue Market Share by Regions (2013-2018)
Figure Global Multiple Sclerosis Revenue Market Share by Regions in 2017
Figure North America Multiple Sclerosis Revenue and Growth Rate (2013-2018)
Figure Europe Multiple Sclerosis Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Multiple Sclerosis Revenue and Growth Rate (2013-2018)
Figure South America Multiple Sclerosis Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Multiple Sclerosis Revenue and Growth Rate (2013-2018)
Table North America Multiple Sclerosis Revenue by Countries (2013-2018)
Table North America Multiple Sclerosis Revenue Market Share by Countries (2013-2018)
Figure North America Multiple Sclerosis Revenue Market Share by Countries (2013-2018)
Figure North America Multiple Sclerosis Revenue Market Share by Countries in 2017
Figure USA Multiple Sclerosis Revenue and Growth Rate (2013-2018)
Figure Canada Multiple Sclerosis Revenue and Growth Rate (2013-2018)
Figure Mexico Multiple Sclerosis Revenue and Growth Rate (2013-2018)
Table Europe Multiple Sclerosis Revenue (Million USD) by Countries (2013-2018)
Figure Europe Multiple Sclerosis Revenue Market Share by Countries (2013-2018)
Figure Europe Multiple Sclerosis Revenue Market Share by Countries in 2017
Figure Germany Multiple Sclerosis Revenue and Growth Rate (2013-2018)
Figure UK Multiple Sclerosis Revenue and Growth Rate (2013-2018)
Figure France Multiple Sclerosis Revenue and Growth Rate (2013-2018)
Figure Russia Multiple Sclerosis Revenue and Growth Rate (2013-2018)
Figure Italy Multiple Sclerosis Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Multiple Sclerosis Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Multiple Sclerosis Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Multiple Sclerosis Revenue Market Share by Countries in 2017
Figure China Multiple Sclerosis Revenue and Growth Rate (2013-2018)
Figure Japan Multiple Sclerosis Revenue and Growth Rate (2013-2018)
Figure Korea Multiple Sclerosis Revenue and Growth Rate (2013-2018)
Figure India Multiple Sclerosis Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Multiple Sclerosis Revenue and Growth Rate (2013-2018)
Table South America Multiple Sclerosis Revenue by Countries (2013-2018)
Table South America Multiple Sclerosis Revenue Market Share by Countries (2013-2018)
Figure South America Multiple Sclerosis Revenue Market Share by Countries (2013-2018)
Figure South America Multiple Sclerosis Revenue Market Share by Countries in 2017
Figure Brazil Multiple Sclerosis Revenue and Growth Rate (2013-2018)
Figure Argentina Multiple Sclerosis Revenue and Growth Rate (2013-2018)
Figure Colombia Multiple Sclerosis Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Multiple Sclerosis Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Multiple Sclerosis Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Multiple Sclerosis Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Multiple Sclerosis Revenue Market Share by Countries in 2017
Figure Saudi Arabia Multiple Sclerosis Revenue and Growth Rate (2013-2018)
Figure UAE Multiple Sclerosis Revenue and Growth Rate (2013-2018)
Figure Egypt Multiple Sclerosis Revenue and Growth Rate (2013-2018)
Figure Nigeria Multiple Sclerosis Revenue and Growth Rate (2013-2018)
Figure South Africa Multiple Sclerosis Revenue and Growth Rate (2013-2018)
Table Global Multiple Sclerosis Revenue (Million USD) by Type (2013-2018)
Table Global Multiple Sclerosis Revenue Share by Type (2013-2018)
Figure Global Multiple Sclerosis Revenue Share by Type (2013-2018)
Figure Global Multiple Sclerosis Revenue Share by Type in 2017
Table Global Multiple Sclerosis Revenue Forecast by Type (2018-2023)
Figure Global Multiple Sclerosis Market Share Forecast by Type (2018-2023)
Figure Global Injectable agents Revenue Growth Rate (2013-2018)
Figure Global Oral agents Revenue Growth Rate (2013-2018)
Table Global Multiple Sclerosis Revenue by Application (2013-2018)
Table Global Multiple Sclerosis Revenue Share by Application (2013-2018)
Figure Global Multiple Sclerosis Revenue Share by Application (2013-2018)
Figure Global Multiple Sclerosis Revenue Share by Application in 2017
Table Global Multiple Sclerosis Revenue Forecast by Application (2018-2023)
Figure Global Multiple Sclerosis Market Share Forecast by Application (2018-2023)
Figure Global Hosptial Revenue Growth Rate (2013-2018)
Figure Global Research Revenue Growth Rate (2013-2018)
Figure Global Multiple Sclerosis Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Multiple Sclerosis Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Multiple Sclerosis Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Multiple Sclerosis Revenue Market Forecast (2018-2023)
Figure Europe Multiple Sclerosis Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Multiple Sclerosis Revenue Market Forecast (2018-2023)
Figure South America Multiple Sclerosis Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Multiple Sclerosis Revenue Market Forecast (2018-2023)
  • Global Fingolimod Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Fingolimod market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Fingolimod is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Fingolimod is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Multiple Sclerosis Drugs Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The Multiple Sclerosis Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Multiple Sclerosis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provi......
  • Global Multiple Sclerosis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118
    Market Overview of Global Multiple Sclerosis market: According to our latest research, the global Multiple Sclerosis market looks promising in the next 5 years. As of 2022, the global Multiple Sclerosis market was estimated at USD 13809.22 million, and it's anticipated to reach USD 21672.55 million in 2028, with a CAGR of 7.8% during the forecast years. Multiple sclerosis (MS) is a chronic inflammatory neuropathy characterized by demyelination, axonal transection, and neurode......
  • Fingolimod - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 77
    The global Fingolimod market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Fingolimod in various end use industries. The expanding demands from the Medical Field, Science Research Field and Other Fields,, are propelling Fingolimod market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Inj......
  • Global Fingolimod Market Research Report 2023, Forecast to 2028
    Published: 19-Dec-2023        Price: US 2680 Onwards        Pages: 133
    Fingolimod, sold under the brand name Gilenya, is an immunomodulating medication, mostly used for treating multiple sclerosis (MS). Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......
  • Global Fingolimod Professional Survey Report 2023, Forecast to 2028
    Published: 19-Dec-2023        Price: US 3280 Onwards        Pages: 101
    Fingolimod, sold under the brand name Gilenya, is an immunomodulating medication, mostly used for treating multiple sclerosis (MS). Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......
  • Multiple Sclerosis Drugs - Global Market Insights and Sales Trends 2024
    Published: 19-Dec-2023        Price: US 3350 Onwards        Pages: 96
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Multiple Sclerosis Drugs, with both qu......
  • Global Multiple Sclerosis Drugs Market Research Report 2023
    Published: 25-Oct-2023        Price: US 2900 Onwards        Pages: 87
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Multiple Sclerosis Drugs market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Biogen - Sanofi - Novartis - Teva - Merck KGaA - Bayer - ACORDA - Mallinckrodt Segment by Type - Injectable......
  • Global Multiple Sclerosis Drugs Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 13-Jun-2023        Price: US 3260 Onwards        Pages: 122
    Multiple sclerosis (MS) is the most common disabling neurological disease in young people worldwide. The Multiple Sclerosis Drugs market revenue was 15099.44 Million USD in 2022, and will reach 23584.78 Million USD in 2028, with a CAGR of 7.72% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Multiple Sclerosis Drugs industry, and breaks down according to the type, application, and consumption area of Multiple Sclero......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs